Developments in the treatment of carcinoid syndrome – impact of telotristat
David L Chan, Simron Singh Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Abstract: Carcinoid syndrome occurs in 20% of patients with neuroendocrine tumors, and serotonin is usually the main causative hormonal peptide. Carcinoid syndrome, and particularly diarrhea, ca...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018-02-01
|
| Seri Bilgileri: | Therapeutics and Clinical Risk Management |
| Konular: | |
| Online Erişim: | https://www.dovepress.com/developments-in-the-treatment-of-carcinoid-syndrome-impact-of-telotris-peer-reviewed-article-TCRM |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|